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  
Abstract — A deep learning network was used to predict 
future blood glucose levels, as this can permit diabetes 
patients to take action before imminent hyperglycaemia and 
hypoglycaemia. A sequential model with one long-short-term 
memory (LSTM) layer, one bidirectional LSTM layer and 
several fully connected layers was used to predict blood 
glucose levels for different prediction horizons. The method 
was trained and tested on 26 datasets from 20 real patients. 
The proposed network outperforms the baseline methods in 
terms of all evaluation criteria. 
Keywords — blood glucose level, diabetes, prediction, 
long-short-term memory network. 
 
I. INTRODUCTION 
iabetes mellitus is a group of metabolic diseases 
characterised by hyperglycemia resulting from defects 
in insulin secretion, insulin action, or both [1]. Diabetes can 
be mainly classified into Type 1 diabetes (T1D) and Type 2 
diabetes (T2D), where the former is caused by destruction 
of the pancreatic beta cells resulting in insulin deficiency, 
while the latter due to the ineffective use of insulin. The 
chronic hyperglycaemia of diabetes is associated with 
long-term damage, dysfunction, and failure of various 
organs, especially the eyes, kidneys, nerves, heart, and 
blood vessels [1]. Besides hyperglycaemia, hypoglycaemic 
events should also be prevented, as these can lead to 
unconsciousness, coma, and even death. 
 To keep blood glucose (BG) concentrations within a 
healthy range, T1D patients need external insulin, which 
can be delivered via syringes, insulin pens or insulin pumps 
[2]. This treatment can be improved by combining a pump 
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for continuous subcutaneous insulin infusion (CSII) and a 
device for continuous glucose monitoring (CGM); this is 
known as sensor-augmented pump (SAP) therapy [3]. SAP 
therapy can be extended by introducing control algorithms 
to provide automatic insulin delivery. It is then referred to 
as the “Artificial Pancreas” (AP) system [4].  
 The CGM device can measure blood glucose level every 
5 minutes, which means 288 measurements per day. This 
nearly continuous monitoring not only improves the 
evaluation of the current treatment, but also makes it 
possible to predict future blood glucose levels. If any 
hyperglycaemia or hypoglycaemia could be accurately 
predicted, the patients or the control algorithm could 
proactively take measures to avoid this. 
 Various methods have been investigated to predict blood 
glucose. Shanthi [5] introduced a classical statistical 
method, i.e. an autoregressive integrated moving average 
(ARIMA) model-based algorithm [6] to predict blood 
glucose in 30 to 60 minutes prediction horizons. Machine 
learning methods were introduced for blood glucose 
prediction, e.g. Daskalaki et al. [7], used a real-time 
learning recurrent neural network (RNN) fed with both 
glucose and insulin information. The model outperformed 
both an autoregressive (AR) model using glucose 
information, as well as an AR model with external insulin 
input (ARX); Bunescu et al. [8] proposed the use of support 
vector regression (SVR) for glucose prediction, by taking 
into consideration daily events, such as insulin boluses and 
meals; Georga et al. [9] proposed an approach which 
combined meal model, insulin model, exercise model and 
used SVR method to provide individualized glucose 
prediction. Deep learning methods recently proved to 
outperform the already established methodologies. This is 
due to the property of automatically extracting relevant 
features from the training samples in order to accurately 
predict the blood glucose. Mhaskar et al.[10] proposed a 
deep convolutional neural network (DCNN), which 
outperformed shallow network. One of the major 
challenges in designing systems using classical RNNs is 
their limited capacity to learn long-term dependencies, 
because of the vanishing or exploding gradient problem 
[11]. Recent deep RNNs incorporate mechanisms to 
address this problem [12], e.g. long-short-term memory 
(LSTM) which introduces the memory cell and forget gate 
into classical RNN network [13]. The memory cells enable 
the networks to improve prediction feasibility by 
combining its memories and the inputs, while the forget 
gate defines the information from the old state that can 
remain in the network. LSTM based networks have shown 
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promising results for time series prediction, and have been 
applied to predict stock prices [14], highway trajectories 
[15], sea surface temperatures [16], or to learn the 
physiological models of blood glucose behaviour [17] etc. 
LSTM can learn much faster than other networks and solve 
complex tasks that have never been solved by previous 
recurrent network algorithms [13]. By incorporating with a 
bidirectional structure, each cell of LSTM is enabled to 
access the context from the both past and future directions. 
A deep bidirectional LSTM (Bi-LSTM) structure was 
introduced for blood pressure prediction by Su et al. [18].  
In this work, we focus on using a LSTM and 
bidirectional LSTM based deep neural network to predict 
blood glucose levels based on CGM measurements. As 
baseline, we used the prediction results from the ARIMA 
model and SVR method. In this preliminary study, only 
blood glucose data were considered as feature for the 
prediction.  
II. METHODOLOGY 
In this section, the methods and models used are briefly 
presented. The setup of the prediction model and training 
phase are also introduced. 
A. LSTM network 
LSTM is a variant of an RNN network, as  proposed by 
Hochreiter and Schmidhuber in 1997 [13]. The LSTM 
network solves the long-term dependency problem that 
occurs in classical RNNs, by introducing memory C and the 
gate structure. 
 Fig.1. illustrates the structure of the LSTM cell [19], 
which has four gates, i.e. input gate i, forget gate f, control 
gate c, and output gate o.  
 
 
Fig. 1. Structure of the LSTM cell 
 
 The input gate decides which information can be 
transferred to the cell, which can be defined as: 
 𝑖𝑡 = 𝜎(𝑊𝑖 ∙ [ℎ𝑡−1, 𝑥𝑡] + 𝑏𝑖)  (1) 
The forget gate decides which information from input 
should be neglected from the previous memory and is 
defined as: 
 𝑓𝑡 = 𝜎(𝑊𝑓 ∙ [ℎ𝑡−1, 𝑥𝑡] + 𝑏𝑓) (2) 
The control gate controls the update of cell state from Ct-1 
to Ct , based on equations (3) and (4).  
 ?̃?𝑡 = 𝑡𝑎𝑛ℎ(𝑊𝐶 ∙ [ℎ𝑡−1, 𝑥𝑡] + 𝑏𝐶) (3) 
 𝐶𝑡 = 𝑓𝑡 ∗ 𝐶𝑡−1 + 𝑖𝑡 ∗ ?̃?𝑡 (4) 
The output gate is responsible for generating the output 
and updating the hidden vector ht-1.This process can be 
defined as:  
 𝑜𝑡 = 𝜎(𝑊𝑜 ∙ [ℎ𝑡−1, 𝑥𝑡] + 𝑏𝑜) (5) 
 ℎ𝑡 = 𝑜𝑡 ∗ tanh (𝐶𝑡) (6) 
In equations (1) to (6) 𝜎  is the sigmoid activation 
function, the Ws are the corresponding weight matrices, and 
tanh is used to scale the values into the range -1 to 1.  
B. Bidirectional LSTM network 
Bidirectional recurrent neural networks (BRNN) were 
first introduced by Schuster and Paliwal in 1997. BRNN 
can be trained using all available input information in the 
past and future of a specific time [20]. By splitting the state 
neurons of a regular RNN into the positive and negative 
time directions, the network isolates the outputs from 
forward states and backward states. During the training 
process, BRNN is trained in both forward and backward 
directions. Fig.2. shows the general structure of BRNN. 
Bidirectional structure can be applied to the variants of the 
RNNs; in this work we used bidirectional LSTM. 
 
 
Fig. 2. General structure of BRNN 
 
C. Prediction model and training setup 
We built the prediction model with the high-level neural 
networks API Keras version 2.0.8 in the Python 3.4.3 
environment.  
We considered one LSTM layer and one bidirectional 
LSTM layer, each with 4 units, and three fully connected 
layers with 8, 64 and 8 units, respectively. The output layer, 
the one unit dense layer, was used to output the final 
predicted blood glucose value. Fig.3. shows the input and 
output dimension of each layer. The number of train epochs 
was fixed by 100 iterations.  
Two rounds of pre-train, with in silico data as well as real 
patient data, were introduced to generate a generalised 
“global model”. For the pre-train phase, the epoch number 
was determined by running the experiments with 100 to 
2600 iterations (increment is 100 iterations), and the model 
that combines good performance and low numbers of 
iteration is chosen. This will be described in detail in 
section IV. Cross validation (data split: 67%, 33%) was 
used to prevent over-fitting during pre-train and train 
phases. 
III. DATASETS AND EVALUATION CRITERIA 
Both real patients datasets and in silico datasets were used 
in this work.  
 
 
Fig. 3. Input and output dimensions of each layer 
 
A. Datasets from real patients 
The datasets, which were described in [21], were from a 
pilot prospective randomised controlled crossover study 
(NCT02546063) of GoCARB [22]. In total, 20 adults with 
T1D (mean age 35 ± 14 years, duration of diabetes 17  ± 10 
years) were involved. In this work, we only used the CGM 
measurements, which were measured with 5 minutes 
sampling time. The 20 datasets contain 6975 ± 1612 
measurements. 
The datasets were pre-processed to overcome i) single 
outliers between two normal measurements, ii) lack of 
measurements for a period. Linear interpolation was used to 
calculate the missing data in situation i). As in future work 
more features will be involved in prediction, the original 
datasets for situation ii) were divided into sub-datasets, 
which have valid measurements of all the variables (i.e. 
CGM measurements, basal rate, bolus amount etc.).    
Then we chose the sub-datasets with the minimum length 
of 1500 measurements (at least 5 days). On the basis of this 
pre-processing and selection, in total 26 sub-datasets 
(length: 1791 ± 141) could meet the requirements. The 
remaining sub-datasets, which have fewer than 1500 
measurements, were merged into a single data file that was 
used to pre-train the network. 
B. Datasets from in silico trials 
We used the FDA-accepted UVa/Padova T1D Simulator 
to establish 38-day in silico clinical trials for 11 virtual 
adult subjects. A virtual CGM with sampling time 5 
minutes was used; the glucose measurements were 
extracted and merged into a single file for pre-train purpose. 
TABLE I shows the overview of the datasets. 
 
 
 
TABLE I: OVERVIEW OF DATASETS 
 
Simulation 
data 
Real data 1 
(length<1500) 
Real data 2 
(length>1500) 
Usage 
1st round 
pre-train 
2nd round 
pre-train 
67% - train 
33% - test 
Number of 
Datasets 
1 1 26 
Samples 120395 93443 1791±141 
Mean 
Glucose 
(mg/dL) 
131.29 161.45 154.9±25.7 
Hypo- 
Number 
33 234 9±8 
Hyper- 
Number 
616 640 19±7 
Hypo: Glucose value lower than 70 mg/dl 
Hyper: Glucose value above 180 mg/dl 
C. Evaluation criteria 
Root mean square error (RMSE, [mg/dl]), correlation 
coefficient (CC), time lag (TL, [min]) and fit were used to 
evaluate the prediction performance. The evaluation criteria 
indicate the overall prediction ability of the models by 
comparing the test datasets and the predicted value. 
RMSE indicates the difference between the target data 
and the predicted data. This is calculated by taking the 
square root of the mean of the square of all the errors (7). A 
lower RMSE means better prediction performance.  
 RMSE = √𝐸((𝐺 − ?̂?)2) = √
1
𝑁
∑(𝐺 − ?̂?)2  (7) 
where 𝐺 and ?̂? are the actual and predicted glucose values 
respectively.  
 CC represents the linear dependence between two 
datasets and is calculated by 
 𝐶𝐶𝑥𝑦 =
𝜎𝑥𝑦
𝜎𝑥𝜎𝑦
  (8) 
where 𝜎𝑥 and 𝜎𝑦 are the standard deviations and 𝜎𝑥𝑦 is the 
covariance. For our work, CC could be further described as:  
 𝐶𝐶 =
∑(𝐺−𝐺𝑚𝑒𝑎𝑛)(?̂?−?̂?𝑚𝑒𝑎𝑛)
√∑(𝐺−𝐺𝑚𝑒𝑎𝑛)
2√∑(?̂?−?̂?𝑚𝑒𝑎𝑛)
2
  (9) 
where 𝐺𝑚𝑒𝑎𝑛  and ?̂?𝑚𝑒𝑎𝑛  are the mean value of 𝐺  and 𝐺,̂ 
respectively. 
TL is defined as the minimum time-shift between the 
actual and predicted signal which gives the highest 
correlation coefficient between them [23]. 
 Fit is calculated on the basis of the fraction of RMSE and 
root mean square difference between target and its mean 
value. Equation (10) shows the calculation in detail. For a 
time series, a higher Fit value indicates better prediction 
performance of the algorithm. 
 
 𝐹𝑖𝑡 = (1 −
√
1
𝑁
∑(𝐺−?̂?)2
√
1
𝑁
∑(𝐺−𝐺𝑚𝑒𝑎𝑛)
2
) ∗ 100%  (10) 
IV. EXPERIMENTAL RESULTS 
ARIMA, SVR and LSTM methods were used to predict 
the upcoming blood glucose levels for prediction horizons 
(PH) of 15, 30, 45 and 60 minutes. TABLE II presents the 
prediction results, and the best performance are shown in 
bold, i.e. the lowest RMSE and Time Lag, and the largest 
CC and Fit. The LSTM method outperforms the classic 
methods in all the PHs with respect to all the evaluation 
criteria. It is promising that, in comparison with ARIMA 
and SVR, the LSTM method can simultaneously decrease 
RMSE and Time Lag, while CC and Fit are both increased.  
 
TABLE II: PREDICTION RESULTS OF DIFFERENT METHODS 
PH = 15 minutes 
Methods RMSE CC Time Lag Fit 
ARIMA 12.256 0.972 10.192 76.425 
SVR 11.694 0.973 9.808 77.565 
 LSTM 11.633 0.974 9.423 77.714 
PH = 30 minutes 
Methods RMSE CC Time Lag Fit 
ARIMA 22.924 0.903 22.885 55.923 
SVR 22.135 0.904 20.769 57.644 
LSTM 21.747 0.909 20.385 58.523 
PH = 45 minutes 
Methods RMSE CC Time Lag Fit 
ARIMA 32.588 0.806 37.885 37.463 
SVR 30.628 0.812 34.423 41.595 
LSTM 30.215 0.818 32.692 42.563 
PH = 60 minutes 
Methods RMSE CC Time Lag Fit 
ARIMA 40.841 0.698 52.885 21.694 
SVR 37.422 0.709 47.885 28.893 
LSTM 36.918 0.722 46.346 30.079 
 
For the LSTM method, the epoch number for the two 
rounds of pre-train process was determined by running the 
experiment with epoch number from 100 to 2000, with 
increment of 100. TABLE III shows the results of the 
experiments for PH=30 minutes as an example. When 
performance deteriorates, the background colour of the 
value changes from dark green to dark red. With some 
epoch numbers, e.g. 900, 1300, 1500, 1700, etc., the 
performance is better with respect to all the indices. By 
taking into consideration the balance between performance 
and time cost for pre-train, 1300 was chosen as the pre-train 
epoch number for PH=30 minutes. The pre-train epoch 
numbers for PH=15, 45 and 60 are 900, 1200 and 1800. 
V. CONCLUSION 
In the present study, an LSTM network with one LSTM 
layer, one bi-directional LSTM layer along with several 
fully connected layers were used to predict blood glucose 
concentration. The LSTM network was pre-trained with 
both in silico data and real patient data to generate a “global 
model”. Then the model was trained and tested with 26 real 
datasets, with each dataset containing more than 5-day 
CGM data. The epoch number for the training phase was 
low, which ensures that the method could work rapidly, 
even on a mobile platform. On the basis of the evaluation 
criteria, the LSTM network outperformed the baseline 
methods ARIMA and SVR. In comparison with the 
baselines and in all prediction horizons, the LSTM network 
reduced the RMSE and TL, while CC and Fit were 
increased.  
 
TABLE III: PREDICTION PERFORMANCE OF LSTM METHOD WITH 
DIFFERENT PRE-TRAIN EPOCHS (FOR PH=30 MINUTES) 
Epochs RMSE CC Time Lag Fit 
100 22.649 0.902 21.731 56.749 
200 22.509 0.904 21.539 57.077 
300 22.317 0.904 21.346 57.448 
400 22.140 0.906 20.577 57.778 
500 22.021 0.907 20.962 58.004 
600 22.014 0.907 20.577 58.010 
700 22.064 0.906 20.769 57.918 
800 22.035 0.907 20.962 58.039 
900 21.828 0.908 20.577 58.338 
1000 22.113 0.905 20.769 57.760 
1100 22.137 0.907 20.962 57.813 
1200 22.082 0.907 20.962 57.933 
1300 21.747 0.909 20.385 58.523 
1400 22.025 0.906 20.962 57.967 
1500 21.931 0.908 20.577 58.173 
1600 22.008 0.907 20.577 58.070 
1700 21.804 0.908 20.385 58.429 
1800 21.850 0.908 20.577 58.343 
1900 21.848 0.907 20.769 58.315 
2000 21.982 0.907 20.769 58.113 
 
Since only CGM measurements were needed, the method 
could be used for patients using oral drugs, insulin pens or 
the CSII pump. In the next step, we will include more 
features to improve the performance of the method for 
specific target user groups. An alarm mechanism will be 
implemented to detect the up-coming hyper- and 
hypoglycaemic events, on the basis of the predicted glucose 
concentrations.  
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